Assessing biosafety using NGS-based tests requires a continuum of skills in molecular biology, biocomputing, virology, and quality systems.
Laurent Lafferrère
Advertisement
Laurent Lafferrère, PhD, is chief operating officer at PathoQuest.
Articles by Laurent Lafferrère
Advertisement
Latest Updated Articles
Challenges When Outsourcing Viral Safety ServicesMay 15th 2021
Advertisement
Advertisement
Trending on BioPharm International
1
Zylidac Bio to Scale Prolific's Optogenetic Cell Line Platform to GMP
2
BioNTech, BMS to Pair Pumitamig With Trodelvy in Phase 3 First-Line TNBC Trial
3
Sanofi Begins Construction of EU-Backed Insulin Plant in Frankfurt
4
FDA Grants Accelerated Approval to Ultomiris as First C5 Inhibitor for IgA Nephropathy
5